Algorithmic selection of emboli protection device during the procedure of carotid artery stunting

Size: px
Start display at page:

Download "Algorithmic selection of emboli protection device during the procedure of carotid artery stunting"

Transcription

1 Algorithmic selection of emboli protection device during the procedure of carotid artery stunting Yasuhiro Kawabata, Tetsuya Tsukahara, Shunichi Fukuda, Tomokazu Aoki, Satoru Kawarazaki Department of Neurosurgery, National Hospital Organization Kyoto Medical Center

2 background and purpose of this study Tailored-CAS algorithm has been advocated to decrease complication rate of carotid artery stenting (CAS) 1. Three different types of emboli protection devices (EPDs) are available in the Japanese market. Because each type of EPD has theoretical advantages and limitations, we made an algorithm in the selection of EPD. The purpose of this study is to verify the validity of our algorithm. 1 Piotr Pieniążek et al. Carotid artery stenting according to the tailored CAS algorithm is associated with a low complication rate at 30 days:data from the TARGET CAS study. Kardiol Pol 2012; 70, 4:

3 filter type EPDs FilterWire EZ SpiderFX Embolic Protection Device (filter type)

4 balloon-type EPD

5 proximal occlusive balloon type EPDs during predilatation Mo.Ma proximal cerebral protection device (Medtronic) FilterWireEZ Guardwire 9FrOptimo 9FrOptimo

6 Risk factors of cerebral embolism related to CAS siginal intensity ratio (SIR)! plaque volume High-Risk Plaque for Carotid Artery Stenting Evaluated With 3-Dimensional T1-Weighted Gradient Echo Sequence (Tanemura et al. Stroke 44, , 2013)

7 distal filter distal balloon proximal occlusive balloon advantage flow preservation 6Fr compatible easy to use 6Fr compatible vulnerable plaque vulnerable plaque throughout the procedure disadvantage vulnerable plaque x intolerance intolerance 9Fr compatible troublesome to use more expensive

8 Materials and methods Since 2012, CAS with EPDs was performed in 32 patients in our hospital. Twenty six patients were male, and 6 were female, and the median age is 72 years (64-89 years). There were 9 symptomatic lesions and 23 asymptomatic lesions. 19 patients (59%) were at high risk for carotid endarterectomy. The algorithm was based on the presence of neurological symptom, T1-weighted image of the carotid plaque, the collateral arterial supply, and the lesion length (as shown below).

9 characteristics of the patients sex comorbidity male 26 female 6 coronary artery disease 10 chronic kidney disease 6 age median 72 range side left 15 right 17 degree of stenosis median 80 range risk factors peripheral artery disease 14 malignancy 7 aortic dissection 1 abdominal aoritic aneurysm 1 clinical presentation asymptomatic 24 amaurosis fugax 1 transient ischemic attack 2 hemispheric stroke 5 HTN 26 DM 17 dyslipidemia 18 smoking 13

10 carotid plaque imaging T1WI high unknown T1WI intermediate T1WI low Carotid plaque imaging was routinely performed to identify the vulnerable plaque except two patients who had restenosis after carotid artery stenting. Echograhy was substituted in these patients.

11 procedures (1) premedication: single antiplatelet (2), double antiplatelet (24), triple antiplatelet (3), single antiplatelet+oral anticoagulant (1) double antiplatelet+oral anticoagulant (2) statin (22) systemic heparinization: activated clotting time>280 anesthesia: local approach:transfemoral 21, transbrachial 11 guiding catheter:6fr guiding sheath (19), 8Fr (6), 9Fr (7) stent: CarotidWall (16), Precise (13), Protege (3) predilatation was performed in 26 procedures. postdiltation was performed in 27 procedures.

12 EPDs FilterWireEZ MOMAultra SpiderRX Optimo Filter-type EPDs were used in 15 procedures (47%), and balloon-type EPDs were used in 11 procedures (34%). In 6 cases (19%), proximal endovascular blockage of blood flow was performed only during predilatation or throughout the procedures. In three patients with nearly occluded lesions and a patient in whom intraplaque hemorrhage was suspected by high intensity signal on time-offlight MR angiography1, proximal blockage was selected to prevent distal emboli during crossing of guiding wire or predilatation. 1 S. Yoshimura et al. Stroke. 2011;42: GuardWire

13 a list of patients in whom proximal endovascular blockage was used during the procedure age sex presentation % stenosis lesion length (mm) carotid plaque MRI EPD stent ischemic events 1 84 M asymptomatic high Optimo +guardwire Carotid Wall DWI-high intensity lesions 2 70 F asymptomatic low Optimo +guardwire PRECISE none 3 74 M symptomatic high MOMAUltra Carotid Wall 4 67 M symptomatic high MOMAUltra Carotid Wall none transient hemiparesis (after discharge) 5 75 M asymptomatic high (intraplaque hemorrhage) Optimo +guardwire Carotid Wall DWI-high intensity lesions 6 85 M asymptomatic high Optimo +FilterWireEZ Carotid Wall none

14 Carotid stenosis The presence of symptom asymptomatic symptomatic T1WI of the T1WI of the carotid plaque low~iso carotid plaque low~iso Collateral circulation Lesion length poor good <20mm >20mm Filter type EPD Distal balloon type EPD Proximal occlusive balloon EPD

15 result (1) thromboembolic events intraprocedural: asymptomatic infarction (occipital) 1/32 postprocedural: transient hemiparesis 1/32 (after discharge) hyperintense lesions on diffusion-weighted image: 16/32 (50%)

16 results (2) perioperative myocardial infarction: symptomatic (1), asymptomatic (2) exacerbation of chronic kidney disease: 1 procedure-related 30 day: 0 procedure-related 30 day: 0

17

18

19 conclusion The present study showed that our algorithm in the selection of EPD can be a useful tool in the prevention of cerebral emboli during CAS.

CAROTID ARTERY ANGIOPLASTY

CAROTID ARTERY ANGIOPLASTY CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline

More information

Why I m afraid of occlusive devices

Why I m afraid of occlusive devices Why I m afraid of occlusive devices Cannes 28.06.2008 Carlo Cernetti Cardiology Department Mirano (Venice) MEET 2008 CANNES I HAVE NOT FINACIAL INTEREST/ARRANGEMENT OR AFFILIATION CONFLICT Obstructive

More information

PrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!!

PrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!! PrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!! Prof Piotr Pieniazek MD PhD Jagiellonian University Institute of Cardiology, John Paul II Hospital Krakow, Poland

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting JESSICA MITCHELL, ACNP CENTRAL ILLINOIS RADIOLOGICAL ASSOCIATES External Carotid Artery (ECA) can easily be identified from Internal Carotid Artery (ICA) by noticing the branches.

More information

Tailored carotid artery stenting

Tailored carotid artery stenting Tailored carotid artery stenting is associated with a low complication rate 30-day results from the continued TARGET-CAS study in 1133 consecutive procedures. Lukasz Tekieli, Piotr Pieniazek, Piotr Musialek,

More information

BULgarian Carotid Artery Stenting versus Surgery Study (BULCASSS): Randomized single center trial

BULgarian Carotid Artery Stenting versus Surgery Study (BULCASSS): Randomized single center trial BULgarian Carotid Artery Stenting versus Surgery Study (): Randomized single center trial Ivo Petrov, M. Konteva, H. Dimitrov, K. Kichukov Tokuda Hospital Sofia Cardiology Department Background Carotid

More information

Carotid artery stenting for long CTO and pseudo occlusion of carotid artery -2 case reports-

Carotid artery stenting for long CTO and pseudo occlusion of carotid artery -2 case reports- Carotid artery stenting for long CTO and pseudo occlusion of carotid artery -2 case reports- Katsutoshi Takayama, MD, Ph.D Department of Radiology and Interventional Neuroradiology Ishinkai Yao General

More information

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA Carotid Artery Stenting (CAS) Carotid Artery Stenting for Stroke Risk Reduction Matthew A. Corriere MD, MS, RPVI Assistant Professor of Surgery Department of Vascular and Endovascular Surgery Rationale:

More information

Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC

Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC GVM Care & Research - Cardiovascular Department (Cotignola Italy) Hypothesis: Does CAS present similar outcomes than

More information

Comparison of Five Major Recent Endovascular Treatment Trials

Comparison of Five Major Recent Endovascular Treatment Trials Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline

More information

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Paul Hsien-Li Kao, MD Assistant Professor National Taiwan University Medical School and Hospital ICA stenting

More information

SCAI Fall Fellows Course Subclavian/Innominate Case Presentation

SCAI Fall Fellows Course Subclavian/Innominate Case Presentation SCAI Fall Fellows Course 2012 Subclavian/Innominate Case Presentation Daniel J. McCormick DO, FACC, FSCAI Director, Cardiovascular Interventional Therapy Pennsylvania Hospital University of Pennsylvania

More information

Limitations of Other Embolic Protection Devices - Filters. Carotid Stenting with Flow Reversal. Limitations of Distal Occlusion

Limitations of Other Embolic Protection Devices - Filters. Carotid Stenting with Flow Reversal. Limitations of Distal Occlusion Carotid Stenting with Flow Reversal Marc Schermerhorn, MD Division of Vascular and Endovascular Surgery Beth Israel Deaconess Center Boston, MA Limitations of Other Embolic Protection Devices - Filters

More information

Filters versus Occlusion Balloons during CAS Is there a clear preference?

Filters versus Occlusion Balloons during CAS Is there a clear preference? Washington TCT 2005 Filters versus Occlusion Balloons during CAS Is there a clear preference? K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany Presenter Disclosure Information

More information

Carotid Revascularization

Carotid Revascularization Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical

More information

Subclavian artery Stenting

Subclavian artery Stenting Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control

More information

CAROTID ARTERY ANGIOPLASTY

CAROTID ARTERY ANGIOPLASTY CAROTID ARTERY ANGIOPLASTY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and

More information

Carotid Stenting and Surgery in 2016 in Russia

Carotid Stenting and Surgery in 2016 in Russia Carotid Stenting and Surgery in 2016 in Russia Novosibirsk research institute of circulation pathology named by Meshalkin, Novosibirsk, Russia Starodubtsev V., Karpenko A., Ignatenko P. Annually in Russia

More information

CASE REPORT. Department of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan ABSTRACT

CASE REPORT. Department of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan ABSTRACT Nagoya J. Med. Sci. 79. 559 ~ 564, 2017 doi:10.18999/nagjms.79.4.559 CASE REPORT Crevice sign as an indicator of plaque laceration associated with postoperative severe thromboembolism after carotid artery

More information

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL Carotid Technologies and Protection Issam D. Moussa, MD Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL Disclosure Statement

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACAS (Asymptomatic Carotid Atherosclerosis Study), 65 66 ACST (Asymptomatic Carotid Surgery Trial), 6 7, 65, 75 Age factors, in carotid

More information

Extracranial Carotid Artery Stenting With or Without Distal Protection Device

Extracranial Carotid Artery Stenting With or Without Distal Protection Device Extracranial Carotid Artery Stenting With or Without Distal Protection Device Eak-Kyun Shin MD. Professor of Medicine Division of Cardiology, Heart Center, Gil Medical Center Gacheon Medical School Incheon,

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting Natural history of the carotid stenosis Asymptomatic 80% carotid stenosis - 6% risk of stroke / year Symptomatic carotid stenosis have 10% risk of CVA at one year and 40% at 5 years

More information

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD] 2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available

More information

Aortic arch pathology. Cerebral ischemia following carotid artery stenosis.

Aortic arch pathology. Cerebral ischemia following carotid artery stenosis. Important: -Subclavian Steal Syndrome -Cerebral ischemia Aortic arch pathology. Cerebral ischemia following carotid artery stenosis. Mina Aubeed & Alba Hernández Pinilla Aortic arch pathology Common arch

More information

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery 2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1

More information

The CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent

The CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent The CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent 6 month data Piotr Musialek, MD DPhil FESC Jagiellonian University Dept. of Cardiac & Vascular Diseases John

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting Woong Chol Kang M.D. Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Carotid Stenosis and Stroke ~25% of stroke is due to carotid disease, the reminder

More information

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary SOCIETY FOR VASCULAR SURGERY DOCUMENT Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary John J. Ricotta, MD, a Ali AbuRahma, MD, FACS, b

More information

Future Perspectives of Micromesh Stents Antonio Micari MD Director Cardiovascular Units GVM Care and Research (Palermo, Italy)

Future Perspectives of Micromesh Stents Antonio Micari MD Director Cardiovascular Units GVM Care and Research (Palermo, Italy) Future Perspectives of Micromesh Stents Antonio Micari MD Director Cardiovascular Units GVM Care and Research (Palermo, Italy) Potential conflicts of interest Antonio Micari MD I have the following potential

More information

Carotid artery stents and embolic protection

Carotid artery stents and embolic protection Regulation of Carotid Artery Stents and Embolic Protection Devices in the United States A history of, and perspectives on, FDA regulation of carotid stents and associated embolic protection devices over

More information

Carotid Artery Stent: Is it ready for prime time?

Carotid Artery Stent: Is it ready for prime time? 2010 CATH LAB SYMPOSIUM Carotid Artery Stent: Is it ready for prime time? Luis F. Tami, MD, FACC, FSCAI Interventional Cardiology and Vascular Medicine Memorial Regional Hospital August 2010 CAE and CAS

More information

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease Disclosures Your Patient Has Carotid Bulb Stenosis and a Tandem Intracranial Stenosis: How Do SAMMPRIS and Other Evidence Inform Your Treatment? UCSF Vascular Symposium 2015 Steven W. Hetts, MD Associate

More information

Carotid Artery Stenosis

Carotid Artery Stenosis Evidence-Based Approach to Carotid Artery Stenosis Seong-Wook Park, MD Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Carotid Artery Stenosis Carotid

More information

Small in-stent Low Density on CT Angiography after Carotid Artery Stenting

Small in-stent Low Density on CT Angiography after Carotid Artery Stenting www.centauro.it Interventional Neuroradiology 14 (Suppl. 2): 41-46, 2008 Small in-stent Low Density on CT Angiography after Carotid Artery Stenting MIKA OKAHARA 1, HIRO KIYOSUE 2, JUNJI KASHIWAGI 1, SHINYA

More information

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR ACCIDENTS CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

More information

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis Chee Yang CHIN, MBChB, MRCP(UK) C.W.L. Chin, P.T.L. Chiam, R.S. Tan National Heart Centre Singapore 26

More information

New concepts for filter protection during CAS: double filtration. Alberto Cremonesi MD, FESC

New concepts for filter protection during CAS: double filtration. Alberto Cremonesi MD, FESC New concepts for filter protection during CAS: double filtration Alberto Cremonesi MD, FESC First Experience with the PALADIN Carotid Post-Dilation Balloon with Integrated Embolic Protection Alberto Cremonesi

More information

Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France

Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France www.incathlab.com Disclosure Speaker name: Max Amor, MD.... I have the following

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Endovascular Therapies for Extracranial Vertebral Artery Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: endovascular_therapies_for_extracranial_vertebral_artery_disease

More information

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012 Charles Ashton Medical Director TIA AND STROKE Topics/Order of the day 1 What Works? Clinical features of TIA inc the difference between Carotid and Vertebral territories When is a TIA not a TIA TIA management

More information

ORIGINAL CONTRIBUTION

ORIGINAL CONTRIBUTION ORIGINAL CONTRIBUTION Safety of Latest-Generation Self-expanding Stents in Patients With NASCET-Ineligible Severe Symptomatic Extracranial Internal Carotid Artery Stenosis Italo Linfante, MD; Joshua A.

More information

A transradial approach for carotid artery stenting

A transradial approach for carotid artery stenting A transradial approach for carotid artery stenting Poster No.: C-0494 Congress: ECR 2012 Type: Scientific Exhibit Authors: K. Haraguchi 1, K. Toyama 2, M. Nagai 2, N. Matsuura 2, T. Itou 2 ; 1 2 Hakodate,

More information

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO

More information

How to Choose Among Carotid Embolic Protection Devices?

How to Choose Among Carotid Embolic Protection Devices? How to Choose Among Carotid Embolic Protection Devices? James P. Zidar, M.D., F.A.C.C., F.S.C.A.I. Associate Professor of Medicine Duke University Medical Center Director, Cardiovascular Services Duke

More information

Endovascular treatment for pseudoocclusion of the internal carotid artery

Endovascular treatment for pseudoocclusion of the internal carotid artery Endovascular treatment for pseudoocclusion of the internal carotid artery Daqiao Guo, Xiao Tang, Weiguo Fu Institute of Vascular Surgery, Fudan University, Department of Vascular Surgery, Zhongshan Hospital

More information

Surgical Treatment of Carotid Disease

Surgical Treatment of Carotid Disease Department of Cardiothoracic & Vascular Surgery McGovern Medical School / The University of Texas Health Science Center at Houston Surgical Treatment of Carotid Disease The Old, the New, and the Future

More information

Plaque protrusion during carotid artery stenting: risk factors determined by MR plaque imaging

Plaque protrusion during carotid artery stenting: risk factors determined by MR plaque imaging Plaque protrusion during carotid artery stenting: risk factors determined by MR plaque imaging Katsutoshi Takayama, M.D., Ph.D. Department of Radiology and Interventional neuroradiology, Ishinkai Yao General

More information

Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.

Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure. Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008 New Trials in Progress: ACT 1 Jon Matsumura, MD Cannes, France June 28, 2008 Faculty Disclosure I disclose the following financial relationships: Consultant, CAS training director, and/or research grants

More information

Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke

Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Original Contribution Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Abstract Introduction: Acute carotid artery occlusion carries

More information

Wael Tawfick Sherif Sultan UCHG, NUIG, RCSI

Wael Tawfick Sherif Sultan UCHG, NUIG, RCSI Carotid Artery Stenting Cervical Approach Wael Tawfick Sherif Sultan UCHG, NUIG, RCSI 1. Western Vascular Institute, University College Hospital, Galway, Ireland (UCHG) 2. School of Medicine, National

More information

Co chce/čeká neurochirug od anesteziologa během karotické endarterektomie?

Co chce/čeká neurochirug od anesteziologa během karotické endarterektomie? XXV. kongres České společnosti anesteziologie, resuscitace a intenzivní medicíny, Praha 3.-5.10. 2018 Co chce/čeká neurochirug od anesteziologa během karotické endarterektomie? Hejčl A., Orlický M., Sameš

More information

Diffusion-Weighted Imaging Abnormalities after Percutaneous Transluminal Angioplasty and Stenting for Intracranial Atherosclerotic Disease

Diffusion-Weighted Imaging Abnormalities after Percutaneous Transluminal Angioplasty and Stenting for Intracranial Atherosclerotic Disease AJNR Am J Neuroradiol 26:385 389, February 2005 Diffusion-Weighted Imaging Abnormalities after Percutaneous Transluminal Angioplasty and Stenting for Intracranial Atherosclerotic Disease Tomoyuki Tsumoto

More information

How to Manage LVO Stroke with Access Blocked by Cervical Carotid Occlusion

How to Manage LVO Stroke with Access Blocked by Cervical Carotid Occlusion How to Manage LVO Stroke with Access Blocked by Cervical Carotid Occlusion November 1 st, 2017 Johanna T. Fifi, MD Director, Endovascular Ischemic Stroke Associate Professor of Neurology, Neurosurgery,

More information

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough Todd W GenslerMD April 28, 2018 CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough DISCLOSURES I have no financial disclosures Presenter name

More information

Two Cases of Carotid Artery Stenting Combined Balloon- and Self-expanding Stent for the Spontaneous Internal Carotid Artery Dissections

Two Cases of Carotid Artery Stenting Combined Balloon- and Self-expanding Stent for the Spontaneous Internal Carotid Artery Dissections Journal of Neuroendovascular Therapy 2017; 11: 437 442 Online June 13, 2017 DOI: 10.5797/jnet.tn.2016-0059 Two Cases of Carotid Artery Stenting Combined Balloon- and Self-expanding Stent for the Spontaneous

More information

Contemporary Management of Carotid Disease What We Know So Far

Contemporary Management of Carotid Disease What We Know So Far Contemporary Management of Carotid Disease What We Know So Far Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Disclosers NONE Epidemiology 80 % of stroke are

More information

We Catch. What Others Miss

We Catch. What Others Miss We Catch What Others Miss GORE Embolic Filter Diamond Frame Circumferential Filter Attachment eptfe Filter Media with 100-Micron Pores and Hydrophilic Heparin Coating Diamond Frame designed to enhance

More information

Endovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida

Endovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Carotid Artery Stenting Versus

Carotid Artery Stenting Versus Carotid Artery Stenting Versus Carotid Endarterectomy Seong-Wook Park, MD, PhD, FACC,, Seoul, Korea Stroke & Carotid artery stenosis Stroke & Carotid artery stenosis Cerebrovascular disease is one of the

More information

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure Slide 1 The Treatment of Intracranial Stenosis Helmi Lutsep, MD Vice Chair and Dixon Term Professor, Department of Neurology, Oregon Health & Science University Chief of Neurology, VA Portland Health Care

More information

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery Treatment Considerations for Carotid Artery Stenosis Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery 4.29.2016 There is no actual or potential conflict of interest in regards to this presentation

More information

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA William A. Gray MD System Chief of Cardiovascular Services, President, Wynnewood, PA USA What are the possible causes of stroke in CAS? Operator error Technique (balloon sizing, wire misadventure, EPD

More information

Invasive treatment for carotid fibromuscular dysplasia

Invasive treatment for carotid fibromuscular dysplasia Original paper Invasive treatment for carotid fibromuscular dysplasia Łukasz M. Tekieli 1, Damian R. Maciejewski 1, Karolina Dzierwa 1, Anna Kabłak-Ziembicka 1, Michał Michalski 2, Magdalena Wójcik-Pędziwiatr

More information

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither

More information

Subclavian and Vertebral Artery Angioplasty - Vertebro-basilar Insufficiency: Clinical Aspects and Diagnosis

Subclavian and Vertebral Artery Angioplasty - Vertebro-basilar Insufficiency: Clinical Aspects and Diagnosis HOSPITAL CHRONICLES 2008, 3(3): 136 140 ORIGINAL ARTICLE Subclavian and Vertebral Artery Angioplasty - Vertebro-basilar Insufficiency: Clinical Aspects and Diagnosis Antonios Polydorou, MD Hemodynamic

More information

Update on Carotid Stenting. John R. Laird Cardiovascular Research Institute Washington Hospital Center

Update on Carotid Stenting. John R. Laird Cardiovascular Research Institute Washington Hospital Center Update on Carotid Stenting John R. Laird Cardiovascular Research Institute Washington Hospital Center Carotid Stenting What a Crazy Idea! Pathogenesis of stroke Does it make sense to think that expansion

More information

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? Richard W. Petrella M.D. FACP,FACC,FASCI DEPARTMENT CHAIRMAN CVM&S UPMC HAMOT MEDICAL CENTER 1 LEARNING OBJECTIVES REVIEW THE RISK FACTORS FOR

More information

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Tarvinder Singh, MS, MD Neurohospitalist Swedish Neuroscience Institute 1 Objectives Definition Why the urgency? Evidence/Guidelines

More information

Lecture Outline: 1/5/14

Lecture Outline: 1/5/14 John P. Karis, MD Lecture Outline: Provide a clinical overview of stroke: Risk Prevention Diagnosis Intervention Illustrate how MRI is used in the diagnosis and management of stroke. Illustrate how competing

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

A Patient with Stenosis of the Cervical Internal Carotid Artery in Whom Hyperperfusion Syndrome Occurred after Staged Angioplasty

A Patient with Stenosis of the Cervical Internal Carotid Artery in Whom Hyperperfusion Syndrome Occurred after Staged Angioplasty DOI: 10.5797/jnet.cr.2017-0043 A Patient with Stenosis of the Cervical Internal Carotid Artery in Whom Hyperperfusion Syndrome Occurred after Staged Angioplasty Jun Niimi, Kenta Tasaka, Fumio Nemoto, Takuya

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease Stroke is the 3 rd leading cause of death and the leading

More information

Cerebrovascular Disease

Cerebrovascular Disease Cerebrovascular Disease I. INTRODUCTION Cerebrovascular disease (CVD) includes all disorders in which an area of the brain is transiently or permanently affected by ischemia or bleeding and one or more

More information

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for Post-op Carotid Complications A Nursing Perspective of What to Watch Out for By Kariss Peterson, ARNP Swedish Medical Center Inpatient Neurology Team 1 Post-op Carotid Management Objectives Review the

More information

Carotid Artery Stenting Today: A Few Updating Remarks

Carotid Artery Stenting Today: A Few Updating Remarks Carotid Artery Stenting Today: A Few Updating Remarks Camilo R. Gomez, MD, MBA Director, Alabama Neurological Institute Birmingham, Alabama Disclaimer & Warning Company Pharmaceutical BMS-Sanofi-Aventis

More information

Carotid Stenosis Decision-making

Carotid Stenosis Decision-making Carotid Stenosis Decision-making PHARMACOTHERAPY + INTERVENTION ISOLATED PHARMACOTHERAPY? Carotid Stenosis Decision-making PHARMACOTHERAPY + INTERVENTION ISOLATED PHARMACOTHERAPY RISK OF PROCEDURE Conventional

More information

ORIGINAL PAPER. Overlap stenting for in-stent restenosis after carotid artery stenting

ORIGINAL PAPER. Overlap stenting for in-stent restenosis after carotid artery stenting Nagoya J. Med. Sci. 78. 143 ~ 149, 2016 ORIGINAL PAPER Overlap stenting for in-stent restenosis carotid artery stenting Masahiro Nishihori 1,2, Tomotaka Ohshima 1, Taiki Yamamoto 1, Shunsaku Goto 1, Toshihisa

More information

Int J Clin Exp Med 2018;11(9): /ISSN: /IJCEM

Int J Clin Exp Med 2018;11(9): /ISSN: /IJCEM Int J Clin Exp Med 2018;11(9):10069-10075 www.ijcem.com /ISSN:1940-5901/IJCEM0069372 Case Report Acute cerebral infarction after spontaneous recanalization of extracranial internal carotid artery atherosclerotic

More information

Techniques for Carotid Interventon

Techniques for Carotid Interventon Techniques for Carotid Interventon Jay S. Yadav MD Cleveland, Ohio Disclosures Inventor of Angioguard; fixed and recurring payments from JNJ Advisor: JNJ, Guidant Understand the Patient What is the Cause

More information

Current Status and Perspectives of ACST-2, CREST-2, ECST-2 and ACTRIS. Richard Bulbulia Co-Principal Investigator ACST-2 University of Oxford

Current Status and Perspectives of ACST-2, CREST-2, ECST-2 and ACTRIS. Richard Bulbulia Co-Principal Investigator ACST-2 University of Oxford Current Status and Perspectives of ACST-2, CREST-2, ECST-2 and ACTRIS Richard Bulbulia Co-Principal Investigator ACST-2 University of Oxford Two BIG questions in carotid research Question #1 Should we

More information

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital CAROTID STENTING A 2009 UPDATE Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital TREATMENT FOR CAROTID STENOSIS Best medical management Antiplatelet therapy Antihypertensive

More information

Guidelines for Ultrasound Surveillance

Guidelines for Ultrasound Surveillance Guidelines for Ultrasound Surveillance Carotid & Lower Extremity by Ian Hamilton, Jr, MD, MBA, RPVI, FACS Corporate Medical Director BlueCross BlueShield of Tennessee guidelines for ultrasound surveillance

More information

a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers

a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers The study a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers Conflict of interest have the following potential conflicts of interest to report: Consulting

More information

Tips and Tricks for CAS T-CAR

Tips and Tricks for CAS T-CAR Tips and Tricks for CAS T-CAR H.-H. Eckstein, M. Kallmayer Department for Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University of Munich,, Germany Disclosures Collaborator

More information

Stroke/TIA. Tom Bedwell

Stroke/TIA. Tom Bedwell Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient

More information

My Indications are based on anatomy

My Indications are based on anatomy Update in Carotid Artery Stenting &Stroke Management How to choose the best therapy? My Indications are based on anatomy Max Amor M.D max-amor@wanadoo.fr C.Breton,Z.Chati,G.Ethevenot,J.Lemoine,J.P.Simon

More information

Comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR study

Comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR study Comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR study (RADial access for CARotide artery stenting) Zoltán Ruzsa MD PhD et al. TCT 2013 Disclosure Statement of Financial

More information

Two major randomised trials concerning the surgical treatment of carotid artery stenosis

Two major randomised trials concerning the surgical treatment of carotid artery stenosis 944 * See end of article for authors affiliations c CAROTID Correspondence to: Dr Carlo Di Mario, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; c.dimario@rbh.nthames.nhs.uk General cardiology

More information

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea R. Pini, G.L. Faggioli, M. Gargiulo, E. Pisano, A. Pilato, E. Gallitto, C. Mascoli, L.M. Cacioppa, A. Vacirca,

More information

Assessment of the procedural etiology of stroke resulting from carotid artery stenting

Assessment of the procedural etiology of stroke resulting from carotid artery stenting Assessment of the procedural etiology of stroke resulting from carotid artery stenting 1. Study Purpose and Rationale: A. Background Stroke is the 3 rd leading cause of death in the United States and carries

More information

2017 Stroke Statistics

2017 Stroke Statistics 2017 Stroke Statistics 2017 LUMC Stroke Volumes by Type of Stroke Ischemic Stroke Treatment by Type 2017 17% 8% 75% Ischemic Intracerebral Hemorrhage Aneurysmal Subarachnoid Hemorrhage 31 42 25 r-tpa Administered

More information

EXPERIENCE WITH MER SELF- EXPANDIBLE STENT IN CAROTID STENOSIS TREATMENT.

EXPERIENCE WITH MER SELF- EXPANDIBLE STENT IN CAROTID STENOSIS TREATMENT. EXPERIENCE WITH MER SELF- EXPANDIBLE STENT IN CAROTID STENOSIS TREATMENT. FIC 2017. Warsaw. 23/06/2017 JOSÉ M. NAVASA MELADO. Ph RADIOLOGY. HU. MARQUÉS DE VALDECILLA. ! UH. Marqués de Valdecilla. Santander.

More information